| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/29/2009 | WO2009014910A2 N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders |
| 01/29/2009 | WO2009014730A1 Macrocyclic serine protease inhibitors |
| 01/29/2009 | WO2009014674A1 Heterocyclylamides as gut microsomal triglyceride transport protein inhibitors |
| 01/29/2009 | WO2009014637A2 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2009 | WO2009014217A1 Bicyclic pyrrole derivative |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2009013195A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 01/29/2009 | WO2009012958A2 Tubulysin d analogues |
| 01/29/2009 | WO2008063781A3 Chemical compounds as cannabinoid receptor ligands |
| 01/29/2009 | WO2007061661A4 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/29/2009 | US20090030204 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same |
| 01/29/2009 | US20090030203 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030050 Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use |
| 01/29/2009 | US20090030046 N-[3-[(2S)-1-methoxypropan-2-yl]oxy-5-(4-methylsulfonylphenoxy)phenyl]-1H-imidazole-5-carboxamide, used as antidiabetic agents, especially for the treatment of non-insulin dependent diabetes |
| 01/29/2009 | US20090030024 Thiazoles as fungicides |
| 01/29/2009 | US20090030018 Benzimidazole derivatives and their use for modulating the gabaalpha receptor complex |
| 01/29/2009 | US20090030016 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 01/29/2009 | US20090030000 Antiviral agents |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029997 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029976 e.g. [5-(1-cyclobutyl-piperidin-yloxy)-benzofuran-2-yl]-(4,4-difluoro-piperidin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor (H3 receptor); antidepressant, antiepileptic agent, analgesic, anticonvulsant, motion seackness |
| 01/29/2009 | US20090029973 growth factor receptor tyrosine kinase inhibitor; anticarcinogenic agents; N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide |
| 01/29/2009 | US20090029863 Pesticides and uses thereof |
| 01/29/2009 | US20090028787 Novel Heteroaryl Substituted Benzothiazoles |
| 01/29/2009 | US20090026928 Made by reacting an N,N'-diarylbenzidine with a 2-bromo-5-phenylphenothiazine or 3-bromo-10-phenylphenoxazine to form corresponding N,N'-bis-(phenoxazine or phenothiazine)-N,N'-diphenylbenzidine; OLEDs; hole injection layer or a hole transport layer; thermal stability |
| 01/29/2009 | CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity |
| 01/29/2009 | CA2693967A1 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2009 | CA2693207A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 01/29/2009 | CA2693169A1 N-linked heterocyclic receptor agonists for the treatment of metabolic disorders |
| 01/28/2009 | EP2018375A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 01/28/2009 | EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/28/2009 | EP2018367A1 Novel microbiocides |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356171A N4-phenyl-quinaz0line-4-amine derivatives and related compounds as ERBBI type receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 01/28/2009 | CN101356161A Heterocyclic CETP inhibitors |
| 01/28/2009 | CN101356156A Aspartic protease inhibitors |
| 01/28/2009 | CN101355968A Compositions and methods for treating thrombocytopenia |
| 01/28/2009 | CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/27/2009 | US7482465 Indol derivatives and their use as 5-HT ligands |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482366 Modulators of LXR |
| 01/27/2009 | US7482358 2-(5-cyano-3-pyridyl)-4-(4-fluorophenyl)-4-(6-fluoro-3-pyridyl)-5-methyl-2-imidazoline; obesity, bulimia; antidiabetic agents; neuropeptide Y receptor antagonists |
| 01/27/2009 | US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 01/27/2009 | US7482350 4,5-disubstituted-2-aryl pyrimidines |
| 01/27/2009 | US7482344 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482339 Cannabinoid receptor agonists; antipruritic agents, analgesics, bronchodilator agents |
| 01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/27/2009 | CA2355243C Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/27/2009 | CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 01/22/2009 | WO2009012421A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | WO2009012280A2 Benzimidazole poly(adp-ribose)polymerase inhibitors |
| 01/22/2009 | WO2009012252A1 Aminoalkylazole derivatives as histamine-3 antagonists |
| 01/22/2009 | WO2009012242A2 Sodium channel inhibitors |
| 01/22/2009 | WO2009011880A2 Heterocyclic modulators of pkb |
| 01/22/2009 | WO2009010871A2 Pyrazole derivatives as antagonists of adenosine a3 receptor |
| 01/22/2009 | WO2009010530A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 01/22/2009 | WO2009010455A2 Pyrazole derivatives as modulators of metabotropic glutamate receptors |
| 01/22/2009 | WO2009010299A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/22/2009 | WO2009010260A2 Condensed anthranilamide insecticides |
| 01/22/2009 | WO2008130021A3 Heterocyclic hydrazide compound and pesticidal use of the same |
| 01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/22/2009 | US20090023924 Processes for the preparation of isothiazole derivatives |
| 01/22/2009 | US20090023788 Treatment of CRTH2-mediated diseases and conditions |
| 01/22/2009 | US20090023753 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents |
| 01/22/2009 | US20090023748 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023733 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof |
| 01/22/2009 | US20090023713 Heterocyclic compounds |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/22/2009 | US20090022915 Particle and preparation containing the particle |
| 01/22/2009 | US20090022688 Inhibitors of serine protease, particularly hcv ns3-ns4a protease |
| 01/22/2009 | CA2696016A1 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/22/2009 | CA2695004A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | CA2694475A1 Quinazolinamide derivatives |
| 01/22/2009 | CA2693594A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | CA2693588A1 Sodium channel inhibitors |
| 01/22/2009 | CA2693232A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/22/2009 | CA2693138A1 Aminoalkylazole derivatives as histamine-3 antagonists |
| 01/22/2009 | CA2692713A1 Heterocyclic modulators of pkb |
| 01/22/2009 | CA2691507A1 5-membered heterocyclic amides and related compounds |
| 01/22/2009 | CA2690761A1 Benzimidazole poly(adp-ribose)polymerase inhibitors |